What is a stock summary page? Click here for an overview.
Business Description
Revelation Biosciences Inc
NAICS : 541715
SIC : 2834
ISIN : US76135L5075
Share Class Description:
REVB: Ordinary SharesDescription
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.71 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 84.3 | |||||
| 3-Year EPS without NRI Growth Rate | 55.1 | |||||
| 3-Year FCF Growth Rate | 78.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 71.07 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.04 | |||||
| 9-Day RSI | 42.21 | |||||
| 14-Day RSI | 37.63 | |||||
| 3-1 Month Momentum % | -66.29 | |||||
| 6-1 Month Momentum % | -73.25 | |||||
| 12-1 Month Momentum % | -91.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.43 | |||||
| Quick Ratio | 3.43 | |||||
| Cash Ratio | 3.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -705.2 | |||||
| Shareholder Yield % | -220.92 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -305.14 | |||||
| ROA % | -143.1 | |||||
| ROIC % | -515.71 | |||||
| 3-Year ROIIC % | -4517.05 | |||||
| ROC (Joel Greenblatt) % | -11360.4 | |||||
| ROCE % | -161.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.3 | |||||
| Price-to-Tangible-Book | 0.3 | |||||
| EV-to-EBIT | 0.5 | |||||
| EV-to-EBITDA | 0.5 | |||||
| EV-to-FCF | 0.22 | |||||
| Price-to-Net-Current-Asset-Value | 0.3 | |||||
| Price-to-Net-Cash | 0.31 | |||||
| Earnings Yield (Greenblatt) % | 200 | |||||
| FCF Yield % | -756.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:REVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Revelation Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -139.86 | ||
| Beta | -0.57 | ||
| 3-Year Sharpe Ratio | -1.74 | ||
| 3-Year Sortino Ratio | -1.95 | ||
| Volatility % | 52.83 | ||
| 14-Day RSI | 37.63 | ||
| 14-Day ATR ($) | 0.33459 | ||
| 20-Day SMA ($) | 2.979 | ||
| 12-1 Month Momentum % | -91.61 | ||
| 52-Week Range ($) | 2.36 - 60.8 | ||
| Shares Outstanding (Mil) | 0.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Revelation Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Revelation Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Revelation Biosciences Inc Frequently Asked Questions
What is Revelation Biosciences Inc(REVB)'s stock price today?
The current price of REVB is $2.68. The 52 week high of REVB is $60.80 and 52 week low is $2.36.
When is next earnings date of Revelation Biosciences Inc(REVB)?
The next earnings date of Revelation Biosciences Inc(REVB) is .
Does Revelation Biosciences Inc(REVB) pay dividends? If so, how much?
Revelation Biosciences Inc(REVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers